Ameriprise Financial Inc Uni Qure N.V. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Ameriprise Financial Inc holds 851,070 shares of QURE stock, worth $5.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

851,070

Previous 709,435 19.96%

Holding current value

$5.46 Million

Previous $3.69 Million 3.33%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $621,777 - $769,078	141,635 Added 19.96%	851,070 $3.81 Million
Q1 2024 May 15, 2024	SELL	$4.82 - $6.93 $534,176 - $768,017	-110,825 Reduced 13.51%	709,435 $3.69 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $2.51 Million - $3.69 Million	445,795 Added 119.05%	820,260 $5.55 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $193,053 - $340,360	-28,771 Reduced 7.14%	374,465 $2.51 Million
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $401,020 - $800,598	-36,063 Reduced 8.21%	403,236 $4.62 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $298,863 - $368,704	-15,982 Reduced 3.51%	439,299 $8.85 Million
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $903,898 - $1.36 Million	-49,884 Reduced 9.87%	455,281 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $440,070 - $661,920	25,917 Added 5.41%	505,165 $9.48 Million
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $110,078 - $171,186	-8,371 Reduced 1.72%	479,248 $8.93 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $4.82 Million - $7.13 Million	331,509 Added 212.36%	487,619 $8.81 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $7 Million - $12.5 Million	-345,891 Reduced 68.9%	156,110 $3.24 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $7.22 Million - $10.6 Million	277,610 Added 123.72%	502,001 $16.1 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $25,144 - $31,185	-839 Reduced 0.37%	224,391 $6.91 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $5.06 Million - $7.27 Million	-173,048 Reduced 43.45%	225,230 $7.59 Million
Q4 2020 Feb 12, 2021	BUY	$35.35 - $50.67 $9.43 Million - $13.5 Million	266,718 Added 202.73%	398,278 $14.4 Million
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $17,414 - $23,067	-484 Reduced 0.37%	131,560 $4.85 Million
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $2.32 Million - $3.49 Million	51,535 Added 64.01%	132,044 $5.95 Million
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $242,180 - $447,740	6,053 Added 8.13%	80,509 $3.82 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $704,318 - $1.42 Million	18,969 Added 34.19%	74,456 $5.34 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $442,681 - $863,769	-11,247 Reduced 16.85%	55,487 $2.18 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $1.18 Million - $1.83 Million	-22,313 Reduced 25.06%	66,734 $5.21 Million
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $1.31 Million - $3.28 Million	-47,895 Reduced 34.97%	89,047 $5.31 Million
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $327,294 - $487,065	-14,355 Reduced 9.49%	136,942 $3.95 Million
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $107,903 - $156,251	3,627 Added 2.46%	151,297 $5.51 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $2.13 Million - $3.87 Million	96,929 Added 191.03%	147,670 $5.58 Million
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $304,875 - $474,429	-17,829 Reduced 26.0%	50,741 $1.19 Million
Q4 2017 Feb 12, 2018	BUY	$9.47 - $19.59 $649,357 - $1.34 Million	68,570	68,570 $1.34 Million

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Uni Qure N.V. Transaction History